Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Ruby Bio, Inc.

Ruby Bio, Inc.

Stage unknownSan Carlos, CArubybio.comOther
Facts
Year of incorporation
2022sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. May 15, 2025
    Form D equity offering · $8.0M (form d sold) · 22 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Ruby Bio, Inc. filed Form D: $7,979,015 sold of $8,979,015, Other”
Investors on record
3 edges
People
3 officers, 2 directors
Timeline
2
  1. Sep 16, 2026
    Ruby Bio, Inc. no longer listed on Fusion Fund Silicon Valley LLC's portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. Jun 9, 2025
    Ruby Bio, Inc. filed Form D: $7,979,015 sold of $8,979,015, Other
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
18 observations
Every observation on this company